2nd Jul 2015 08:07
LONDON (Alliance News) - Allergy Therapeutics PLC Thursday said it will be hosting the Eighth Annual Adjuvants in Allergy Conference in Amsterdam from July 2 to July 4.
At the conference, Dr Albert Roger, director of the Allergy Unit at Universitari Hospital Germans Trias Pujol in Barcelona will present data from Allergy Therapeutics' recent Acarovac efficacy study for the treatment of house dust mite allergies, the company said.
"Allergy Therapeutics is proud to host the Eighth Annual Adjuvants in Allergy Conference, a highly scientific open forum to discuss allergy topics with expert key opinion leaders and allergists from around the world. The aim of the conference is to encourage the medical community to consider innovative solutions for patients suffering from allergies and we are excited to be at the forefront of these discussions," Chief Executive Manuel Llobet said in a statement.
Shares in Allergy Therapeutics were trading down 2.1% at 23.00 pence Thursday morning.
By Karolina Kaminska; [email protected] @KarolinaAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.